Deepening Drug Discovery Digitalization at PTC Therapeutics

[Article Title]

PTC Therapeutics is a biopharmaceutical company based in New Jersey that focuses on the development and commercialization of innovative therapies for rare genetic diseases. The organization wanted to move away from the manual process of exporting their data into a separate spreadsheet, especially when needing to quickly compare structure-related property trends of multiple compounds. They shifted their focus towards digitalizing workflows and integrating tools and systems for expanded use and a better return on investment.

In this case study from Revvity Signals, learn more about how the Research Informatics team at PTC Therapeutics adopted a software suite that allows for high-throughput screening (HTS) of hundreds of thousands of compounds with minimal user intervention, providing the medicinal chemists with quick and seamless access to predicted data.

Download the Document

    Complete the form below to download the white paper. Already have an account? to prefill your details.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.